Wayne J. Thomspon - Lansdale PA Pierre Mallorga - Lansdale PA Richard W. Ransom - New Britain PA Ian M. Bell - Harleysville PA Michael F. Sugrue - Blue Bell PA Peter M. Munson - Harleysville PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61F 200 A01N 4340 A61K 31445
US Classification:
424427
Abstract:
This invention is concerned with novel 1-�cycloalkylpioeridin-4-yl!-2H benzimidazolones, their compositions and method of use. The novel compounds are selective muscarinic agonists of the m2 subtype with low activity at the m3 subtype. The compounds are effective for the treatment of glaucoma with fewer side effects than the pilocarpine therapy.
Keith M. Witherup - Lansdale PA Richard W. Ransom - New Britain PA Sandor L. Varga - Harleysville PA Steven M. Pitzenberger - Lansdale PA Victor J. Lotti - Harleysville PA William J. Lumma - Pennsburg PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D47104 A61K 3144
US Classification:
514292
Abstract:
A pyrroloquinoline compound of the following formula is disclosed: ##STR1## wherein H, C. sub. 1-6 alkyl, R. sup. 1 is: ##STR2## wherein R is H, C. sub. 1-10 alkyl, or C. sub. 1-6 alkyloxycarbonyl; R. sup. 2 is: H, C. sub. 1-6 alkyl, ##STR3## wherein R. sup. 5 is C. sub. 1-10 alkyl, aryl, or aryl C. sub. 1-10 alkyl; R. sup. 3 is: (CH. sub. 2). sub. n NHR wherein R is H, C. sub. 1-6 alkyl, or C. sub. 1-6 alkyloxycarbonyl; ##STR4## R. sup. 4 is: H, C. sub. 1-6 alkyl, C. sub. 1-6 alkyloxycarbonyl, RCH. sub. 2 --, wherein R is H, C. sub. 1-6 alkyl or aryl, or ##STR5## X is O, or NR. sup. 6 wherein R. sup. 6 is equal to H or C. sub. 1-6 alkyl and n is an integer from 1-3. The compounds of the invention exhibit bradykinin antagonist activity as well as activity with. alpha.
Wayne J. Thompson - Lansdale PA Richard W. Ransom - New Britain PA Pierre Mallorga - Lansdale PA Michael F. Sugrue - Blue Bell PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D21114 C07D23526 C07D23926 A61K 31415
US Classification:
514256
Abstract:
This invention is concerned with novel 1,3-dihydro-1-�1-(1-heteroarylpiperidin-4-yl)piperidin-4-yl!-2H-benzimidaz olones, derivatives thereof, their preparation, method of use and pharmaceutical compositions. These compounds are endowed with antimuscarinic activity and are useful in the treatment and/or prevention of myopia (commonly known as nearsightedness).